Cinnulin PF®
Mechanism of Action +
### The Biochemistry of Cinnamon and Insulin Resistance
Cinnamon has been utilized for centuries in traditional medicine, but its modern application in clinical sports nutrition and endocrinology centers on its ability to modulate glucose metabolism. The primary mechanism by which cinnamon exerts its hypoglycemic effects is through the enhancement of the insulin signaling pathway. However, whole cinnamon bark contains a complex matrix of both water-soluble and fat-soluble compounds. The fat-soluble fractions, particularly cinnamaldehyde and coumarin, can present toxicity issues when consumed in the high doses required to elicit a metabolic effect. Cinnulin PF® bypasses this limitation through Controlled Polymer Purification Technology (CPPT), which selectively extracts the bioactive water-soluble fractions—specifically, Type-A doubly-linked procyanidin polymers.
### Type-A Polymers and Insulin Receptor Kinase Activation
The defining characteristic of Cinnulin PF® is its high concentration of Type-A polymers. At the cellular level, these polymers function as insulin mimetics and insulin sensitizers. The insulin receptor is a transmembrane tyrosine kinase. When insulin binds to the extracellular alpha subunit, it induces a conformational change that leads to the autophosphorylation of the intracellular beta subunit. Type-A polymers from Cinnulin PF® have been shown to directly activate insulin receptor kinase (IRK), thereby increasing the phosphorylation of the insulin receptor even in the presence of suboptimal insulin levels.
Furthermore, these polymers inhibit insulin receptor phosphatase (PTP-1B), the enzyme responsible for dephosphorylating and deactivating the insulin receptor. By simultaneously stimulating the kinase and inhibiting the phosphatase, Cinnulin PF® significantly amplifies the insulin signaling cascade. This dual-action mechanism ensures that the insulin receptor remains in an active, phosphorylated state for a prolonged period, maximizing the cellular response to both endogenous and exogenous insulin.
### Downstream Signaling: PI3K/Akt Pathway and GLUT4 Translocation
Once the insulin receptor is activated, it phosphorylates insulin receptor substrate-1 (IRS-1). This event recruits and activates phosphoinositide 3-kinase (PI3K), which subsequently converts PIP2 to PIP3 at the plasma membrane. PIP3 acts as a docking site for phosphoinositide-dependent kinase-1 (PDK1), which then phosphorylates and activates Akt (Protein Kinase B).
The activation of Akt is the critical node for glucose disposal. Akt phosphorylates AS160 (Akt substrate of 160 kDa), inhibiting its Rab GTPase-activating protein (GAP) activity. This inhibition allows Rab proteins to remain in their active, GTP-bound state, triggering the translocation of GLUT4 (Glucose Transporter Type 4) storage vesicles from the intracellular compartment to the plasma membrane. By enhancing this entire cascade, Cinnulin PF® facilitates a massive influx of glucose into skeletal muscle cells, pulling glucose out of the bloodstream and lowering fasting and postprandial blood sugar levels.
### Glycogen Synthesis and Lipid Metabolism
Beyond glucose uptake, the activation of Akt by Cinnulin PF®'s Type-A polymers has profound implications for nutrient partitioning and body composition. Akt directly phosphorylates and inhibits Glycogen Synthase Kinase-3 beta (GSK-3β). Because GSK-3β normally inhibits Glycogen Synthase, its inhibition by Akt leads to the activation of Glycogen Synthase. This drives the newly internalized glucose toward glycogenesis—the storage of glucose as glycogen in skeletal muscle—rather than de novo lipogenesis (fat storage).
This nutrient partitioning effect explains the clinical findings associated with Cinnulin PF® regarding body composition. By directing carbohydrates into muscle tissue for glycogen replenishment and away from adipocytes, the extract supports an anabolic environment in muscle while promoting a catabolic environment in fat tissue. Clinical data provided by the manufacturer indicates that supplementation with Cinnulin PF® resulted in a 0.7% decrease in body fat and a 1.1% increase in lean muscle mass compared to a placebo, highlighting its efficacy as a body recomposition agent.
### Antioxidant Capacity and Endothelial Function
In addition to its metabolic effects, Cinnulin PF® exhibits potent antioxidant properties. Chronic hyperglycemia induces oxidative stress through the overproduction of reactive oxygen species (ROS) in the mitochondria and the formation of advanced glycation end-products (AGEs). The water-soluble polyphenols in Cinnulin PF® act as direct free radical scavengers and upregulate endogenous antioxidant defense systems, such as superoxide dismutase (SOD) and glutathione peroxidase.
This reduction in systemic oxidative stress is closely linked to the maintenance of normal blood pressure, another clinical benefit attributed to Cinnulin PF®. Oxidative stress impairs endothelial function by reducing the bioavailability of nitric oxide (NO), a potent vasodilator. By neutralizing ROS, Cinnulin PF® preserves NO levels, promoting endothelial relaxation, optimal vasodilation, and healthy blood pressure regulation. This makes it a highly synergistic ingredient in pre-workout formulations designed to maximize muscle pumps and nutrient delivery.
### Pharmacokinetics and the Importance of CPPT
The pharmacokinetics of whole cinnamon are complicated by the presence of coumarin, a naturally occurring benzopyrone that is highly concentrated in Cassia cinnamon (the most common dietary form). Coumarin is rapidly absorbed and metabolized by the liver, but in high doses, it can cause hepatotoxicity and act as an anticoagulant.
The Controlled Polymer Purification Technology (CPPT) used to manufacture Cinnulin PF® is a critical pharmacokinetic advantage. This proprietary aqueous extraction process completely separates the beneficial, water-soluble Type-A polymers from the toxic, fat-soluble coumarin and volatile oils. The resulting extract is highly bioavailable, rapidly absorbed in the gastrointestinal tract, and exerts its peak hypoglycemic effects within 1 to 2 hours post-ingestion. Because it is virtually devoid of coumarin, Cinnulin PF® can be safely dosed at the clinical standard of 250mg twice daily (500mg total) without the hepatic risks associated with consuming equivalent amounts of raw cinnamon powder.
What is Cinnulin PF? +
What is the cinnamon trick to lower blood sugar? +
What happens if we take cinnamon daily? +
What cannot be mixed with cinnamon? +
What medications should not be taken with cinnamon? +
What should you never mix cinnamon with? +
Who should not take a cinnamon supplement? +
Who should not use cassia cinnamon? +
How does Cinnulin PF differ from Ceylon cinnamon? +
What is the recommended dosage for Cinnulin PF? +
Is Cinnulin PF safe for the liver? +
Can Cinnulin PF help with weight loss? +
What is water-extracted cinnamon? +
Does Cinnulin PF contain coumarin? +
When is the best time to take Cinnulin PF? +
Can women with PCOS use Cinnulin PF? +
How long does it take for Cinnulin PF to work? +
Is Cinnulin PF gluten-free and non-GMO? +
Everything About Cinnulin PF® Article
## Introduction to Cinnulin PF®
For decades, athletes, bodybuilders, and health enthusiasts have utilized cinnamon as a natural remedy to control blood sugar and improve metabolism. However, consuming raw cinnamon powder in large quantities presents significant health risks due to the presence of fat-soluble toxins. Enter Cinnulin PF®—a patented, highly purified, water-soluble cinnamon extract designed to deliver the metabolic benefits of cinnamon without the associated toxicity.
Developed by IN-Ingredients (now part of Prinova Global), Cinnulin PF® is widely regarded as the gold standard in cinnamon supplementation. It is a staple ingredient in premium Glucose Disposal Agents (GDAs), pre-workouts, and metabolic health formulas. By isolating the active Type-A polymers from cinnamon bark, Cinnulin PF® acts as a powerful insulin mimetic, driving carbohydrates into muscle tissue, supporting fat loss, and maintaining healthy fasting blood sugar levels.
## The Problem with Standard Cinnamon
To understand the value of Cinnulin PF®, one must first understand the limitations of standard grocery store cinnamon. The most common type of cinnamon available is Cassia cinnamon. While Cassia contains the bioactive compounds that lower blood sugar, it also contains high levels of a naturally occurring compound called coumarin.
Coumarin is a fat-soluble benzopyrone that acts as a blood thinner and has been shown to cause liver damage (hepatotoxicity) when consumed in high doses over time. To get a clinical dose of the active blood-sugar-lowering compounds from raw Cassia cinnamon powder, you would have to consume levels of coumarin that far exceed safe daily limits.
Ceylon cinnamon (often called "true cinnamon") contains much less coumarin, but it is also generally less potent in its blood-sugar-lowering capabilities. This creates a dilemma for those looking to use cinnamon for metabolic enhancement: how do you get the clinical benefits without the liver toxicity?
## The Solution: Controlled Polymer Purification Technology (CPPT)
Cinnulin PF® solves the coumarin problem through a proprietary extraction process known as Controlled Polymer Purification Technology (CPPT).
The bioactive compounds in cinnamon responsible for improving insulin sensitivity are water-soluble. Coumarin and other potentially harmful volatile oils are fat-soluble. The CPPT process uses an aqueous (water-based) extraction method to pull out the beneficial water-soluble compounds while leaving the fat-soluble toxins behind.
The result is an extract that is incredibly rich in active Type-A Polymers but virtually devoid of coumarin. This allows users to consume highly concentrated, clinical doses of cinnamon's active ingredients safely, day after day.
## The Science of Type-A Polymers
The magic of Cinnulin PF® lies in its standardization for Type-A doubly-linked procyanidin polymers. These unique molecular structures have been shown in clinical research to function as both insulin sensitizers and insulin mimetics.
When you consume carbohydrates, your body releases insulin to shuttle the resulting glucose out of your bloodstream and into your cells. In individuals with poor insulin sensitivity, the cells resist this signal, leading to elevated blood sugar and increased fat storage.
Type-A polymers work by directly interacting with the insulin receptor on the surface of your cells. They activate the insulin receptor kinase (the enzyme that turns the receptor "on") and inhibit insulin receptor phosphatase (the enzyme that turns the receptor "off"). This dual action amplifies the insulin signal, causing a cascade of intracellular events that results in GLUT4 transporters moving to the cell surface to pull glucose inside.
## Clinical Benefits and Applications
According to the manufacturer and supported by clinical trials, Cinnulin PF® delivers a wide array of health and performance benefits:
### 1. Regulation of Fasting Blood Sugar In clinical studies, subjects supplementing with Cinnulin PF® demonstrated a significant decrease in fasting blood sugar levels compared to those taking a placebo. By improving the efficiency of glucose uptake, Cinnulin PF® helps maintain a stable, healthy glycemic profile.
### 2. Body Composition and Nutrient Partitioning One of the most exciting applications of Cinnulin PF® is in the realm of body recomposition. Because it drives glucose preferentially into skeletal muscle (to be stored as glycogen) rather than into adipose tissue (to be stored as fat), it acts as a powerful nutrient partitioner. In one study, groups supplementing with Cinnulin PF® saw a 0.7% decrease in body fat and a 1.1% increase in lean muscle mass—changes that were significantly superior to the placebo group.
### 3. Antioxidant Functions and Blood Pressure High blood sugar generates reactive oxygen species (ROS), leading to oxidative stress that damages blood vessels and impairs circulation. The water-soluble polyphenols in Cinnulin PF® are potent antioxidants. By neutralizing these free radicals, Cinnulin PF® helps maintain normal blood pressure and supports overall cardiovascular health.
### 4. Hormone Balance in Women Insulin resistance is a primary driver of hormonal imbalances in women, particularly in conditions like Polycystic Ovary Syndrome (PCOS). By improving insulin sensitivity and lowering circulating insulin levels, Cinnulin PF® can help restore normal endocrine function and support hormone balance.
## Dosage and Stacking Protocols
The clinically recommended dosage of Cinnulin PF® is 250mg taken twice daily, ideally prior to carbohydrate-containing meals, for a total daily dose of 500mg.
In the sports nutrition market, Cinnulin PF® is frequently found in Glucose Disposal Agent (GDA) supplements. In these multi-ingredient formulas, it is often dosed at 125mg to 250mg per serving and stacked synergistically with other insulin sensitizers such as: * **Berberine:** To activate the AMPK pathway. * **Chromium Picolinate:** To further enhance insulin receptor sensitivity. * **Alpha Lipoic Acid (ALA):** To provide additional antioxidant and nutrient partitioning effects.
For athletes looking to maximize muscle fullness and pumps, taking 250mg of Cinnulin PF® alongside a high-carbohydrate pre-workout meal can dramatically enhance glycogen storage and intracellular hydration.
## Safety, Side Effects, and Certifications
Because of the CPPT extraction process, Cinnulin PF® is exceptionally safe. It is: * **Low in Coumarin:** Eliminating the hepatotoxic risks of standard cinnamon. * **Allergen-Free:** Safe for individuals with common food allergies. * **Gluten-Free:** Suitable for celiac and gluten-sensitive individuals. * **GMO-Free:** Sourced from non-genetically modified cinnamon bark.
There are no stimulatory side effects associated with Cinnulin PF®. The primary precaution is for individuals currently taking prescription medications for diabetes (such as Metformin or exogenous insulin). Because Cinnulin PF® actively lowers blood sugar, combining it with hypoglycemic drugs could cause blood sugar to drop too low. Always consult with a healthcare provider before adding a GDA to your regimen if you have a diagnosed metabolic condition.